NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,426.80 -11.70 (-0.48%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,707.68 -238.69 (-0.43%)
Cyclo Therapeutics, Inc. (CYTH)
- Business Wire
Cyclo Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
GAINESVILLE, Fla., May 16, 2024--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the first quarter 2024 and provided a business update.
- Simply Wall St.
Pleasing Signs As A Number Of Insiders Buy Cyclo Therapeutics Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...
- Business Wire
Cyclo Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
GAINESVILLE, Fla., March 18, 2024--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) ("Cyclo Therapeutics" or the "Company"), a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today reported its financial results for the full year 2023 and provided a business update.
